Comorbidity Burden and Guideline-Concordant Care for Breast Cancer

Kimmick, Gretchen; Fleming, Steven T.; Sabatino, Susan A.; Wu, Xiao-Cheng; Hwang, Wenke; Wilson, J. Frank; Lund, Mary Jo; Cress, Rosemary; Anderson, Roger T.

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Comorbidity Burden and Guideline-Concordant Care for Breast Cancer

Published Date:

Feb 10 2014

Source:

J Am Geriatr Soc. 62(3):482-488.

[PDF-103.56 KB]

Details:

Personal Authors:

Kimmick, Gretchen ; Fleming, Steven T. ; Sabatino, Susan A. ; Wu, Xiao-Cheng ; Hwang, Wenke ; ... More ▼

Keywords:

[+]

Pubmed ID:

24512124

Pubmed Central ID:

PMC5869701

Description:

OBJECTIVES

To explore the relationship between level and type of comorbidity and guideline-concordant care for early-stage breast cancer.

DESIGN

Cross-sectional.

SETTING

National Program of Cancer Registry (NPCR) Breast and Prostate Cancer Patterns of Care study, which re-abstracted medical records from 2004 in seven cancer registries.

PARTICIPANTS

Individuals with stage 0–III breast cancer.

MEASUREMENTS

Multicomponent guideline-concordant management was modeled based on tumor size, node status, and hormone receptor status, according to consensus guidelines. Comorbid conditions and severity were measured using the Adult Comorbidity Evaluation Index (ACE-27). Multivariate logistic regression models determined factors associated with guideline-concordant care and included overall ACE-27 scores and 26 separate ACE comorbidity categories, age, race, stage, and source of payment.

RESULTS

The study sample included 6,439 women (mean age 58.7, range 20–99; 76% white; 44% with no comorbidity; 70% estrogen- or progesterone-receptor positive, or both; 31% human epidermal growth factor receptor 2 positive). Care was guideline concordant in 60%. Guideline concordance varied according to overall comorbidity burden (70% for none; 61% for minor; 58% for moderate, 43% for severe; P < .05). In multivariate analysis, the presence of hypertension (odds ratio (OR) = 1.15, 95% confidence interval (CI) = 1.01–1.30) predicted guideline concordance, whereas dementia (OR = 0.45, 95% CI = 0.24–0.82) predicted lack of guideline concordance. Older age (≥50) and black race were associated with less guideline concordance, regardless of comorbidity level.

CONCLUSION

When reporting survival outcomes in individuals with breast cancer with comorbidity, adherence to care guidelines should be among the covariates.

Document Type:

Journal Article

Collection(s):

CDC Public Access

Funding:

Main Document Checksum:

[+]

Supporting Files:

nihms951231.nxml

text/xml

No Related Documents.

You May Also Like:

The influence of diabetes severity on receipt of guideline-concordant treatment for breast cancer

Personal Author:

Sabatino, Susan A.; Thompson, Trevor D.; Wu, Xiao-Cheng; Fleming, Steven T.; Kimmick, Gretchen G.; Trentham-Dietz, Amy; Cress, Rosemary; Anderson, Roger T.;

Published:

Jun 05 2014

Source:

Breast Cancer Res Treat. 146(1):199-209.

Description:

Diabetes severity may influence breast cancer treatment choices. We examined whether receipt of guideline-concordant breast cancer treatment varied with diabetes severity. Cancer registry data from seven states regarding 6,912 stage I-III breast canc...

File Type:

[PDF - 296.47 KB]
Influence of Patient, Physician, and Hospital Characteristics on the Receipt of Guideline-Concordant Care for Inflammatory Breast Cancer

Personal Author:

Denu, Ryan A.; Hampton, John M.; Currey, Adam; Anderson, Roger T.; Cress, Rosemary D.; Fleming, Steven T.; Lipscomb, Joseph; Sabatino, Susan A.; Wu, Xiao-Cheng; Wilson, J. Frank; Trentham-Dietz, Amy;

Published:

Nov 21 2015

Source:

Cancer Epidemiol. 40:7-14.

Description:

Purpose : Inflammatory breast cancer (IBC) is an aggressive subtype of breast cancer for which treatments vary, so we sought to identify factors that affect the receipt of guideline-concordant care. : Methods : Patients diagnosed with IBC in 2004 wer...

File Type:

[PDF - 638.50 KB]
Clinical and Demographic Factors Associated With Receipt of Non Guideline-concordant Initial Therapy for Nonmetastatic Prostate Cancer

Personal Author:

Hamilton, Ann S.; Fleming, Steven T.; Wang, Dian; Goodman, Michael; Wu, Xiao-Cheng; Owen, Jean B.; Lo, Mary; Ho, Alex; Anderson, Roger T.; Thompson, Trevor;

Published:

Feb 2016

Source:

Am J Clin Oncol. 39(1):55-63.

Description:

Objectives : To determine the extent to which initial therapy for nonmetastatic prostate cancer was concordant with nationally recognized guidelines using supplemented cancer registry data and what factors were associated with receipt of nonguideline...

File Type:

[PDF - 617.08 KB]
Patterns of Loco-regional Treatment for Non-Metastatic Breast Cancer by Patient and Health Systems Factors

Personal Author:

Anderson, Roger T.; Morris, Cyllene; Kimmick, Gretchen; Trentham-Dietz, Amy; Camacho, Fabian; Wu, Xiao-Cheng; Sabatino, Susan A.; Fleming, Steven T.; Lipscomb, Joseph;

Published:

Nov 04 2014

Source:

Cancer. 121(5):790-799.

Description:

Purpose : To examine local definitive therapy for non-metastatic breast cancer using the Centers for Disease Control and Prevention’s National Program of Cancer Registries Patterns of Care Breast and Prostate Cancer (POCBP) study. : Patients and Me...

File Type:

[PDF - 1.09 MB]
Type and dose of radiotherapy used for initial treatment of non-metastatic prostate cancer

Personal Author:

Wang, Dian; Ho, Alex; Hamilton, Ann S; Wu, Xiao-Cheng; Lo, Mary; Fleming, Steven; Goodman, Michael; Thompson, Trevor; Owen, Jean;

Published:

Feb 05 2014

Source:

Radiat Oncol. 2014; 9:47.

Description:

Background : We sought to describe patterns of initial radiotherapy among non-metastatic prostate cancer (PC) patients by recurrence risk groups. : Methods : Medical records were abstracted for a sample of 9017 PC cases diagnosed in 2004 as a part of...

File Type:

[PDF - 285.68 KB]